ES486782A0 - Un procedimiento para la preparacion de derivados de imida- zol. - Google Patents
Un procedimiento para la preparacion de derivados de imida- zol.Info
- Publication number
- ES486782A0 ES486782A0 ES486782A ES486782A ES486782A0 ES 486782 A0 ES486782 A0 ES 486782A0 ES 486782 A ES486782 A ES 486782A ES 486782 A ES486782 A ES 486782A ES 486782 A0 ES486782 A0 ES 486782A0
- Authority
- ES
- Spain
- Prior art keywords
- imida
- zol
- derivatives
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7848367 | 1978-12-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8101556A1 ES8101556A1 (es) | 1980-12-16 |
| ES486782A0 true ES486782A0 (es) | 1980-12-16 |
Family
ID=10501705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES486782A Granted ES486782A0 (es) | 1978-12-13 | 1979-12-11 | Un procedimiento para la preparacion de derivados de imida- zol. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US4602016A (es) |
| JP (1) | JPS585197B2 (es) |
| KR (1) | KR830001243B1 (es) |
| AR (1) | AR227637A1 (es) |
| AT (1) | AT373879B (es) |
| AU (1) | AU517892B2 (es) |
| BE (1) | BE880584A (es) |
| CA (1) | CA1108137A (es) |
| CH (1) | CH644597A5 (es) |
| CS (1) | CS216517B2 (es) |
| DD (1) | DD147943A5 (es) |
| DE (1) | DE2950019A1 (es) |
| DK (1) | DK471479A (es) |
| EG (1) | EG14227A (es) |
| ES (1) | ES486782A0 (es) |
| FI (1) | FI70888C (es) |
| FR (1) | FR2444031A1 (es) |
| GB (1) | GB2038821B (es) |
| GR (1) | GR73003B (es) |
| HU (1) | HU183016B (es) |
| IE (1) | IE49318B1 (es) |
| IL (1) | IL58917A (es) |
| IT (1) | IT1194900B (es) |
| LU (1) | LU81985A1 (es) |
| NL (1) | NL177749C (es) |
| NO (1) | NO153135C (es) |
| NZ (1) | NZ192360A (es) |
| PH (1) | PH15056A (es) |
| PL (1) | PL134005B1 (es) |
| PT (1) | PT70571A (es) |
| SE (1) | SE444937B (es) |
| SU (1) | SU878195A3 (es) |
| YU (1) | YU301879A (es) |
| ZA (1) | ZA796708B (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4350696A (en) * | 1980-03-08 | 1982-09-21 | Pfizer Inc. | Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof |
| US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| JPS58113178A (ja) * | 1981-12-28 | 1983-07-05 | Yamanouchi Pharmaceut Co Ltd | 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体 |
| US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
| US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
| NL8301550A (nl) * | 1983-05-03 | 1984-12-03 | Gist Brocades Nv | Imidazolethanol esters. |
| US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| IT1212791B (it) * | 1983-11-24 | 1989-11-30 | Medea Res Srl | Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono. |
| ES8601148A1 (es) * | 1984-12-10 | 1985-11-16 | Ferrer Int | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. |
| JPH0625141B2 (ja) * | 1985-01-16 | 1994-04-06 | 三共株式会社 | イミダゾ−ル誘導体およびその製法 |
| KR920002129B1 (ko) | 1986-01-27 | 1992-03-12 | 상꾜 가부시끼가이샤 | 티아나프텐 유도체의 제조방법 |
| ATE90076T1 (de) | 1986-03-27 | 1993-06-15 | Merck Frosst Canada Inc | Tetrahydrocarbazole ester. |
| JPS63179840A (ja) * | 1986-07-24 | 1988-07-23 | Yamanouchi Pharmaceut Co Ltd | 新規化学物質 |
| ES2018860B3 (es) * | 1987-04-03 | 1991-05-16 | Cl Pharma | Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos |
| JPH01125372A (ja) * | 1988-09-12 | 1989-05-17 | Yamanouchi Pharmaceut Co Ltd | イミダゾリルアルキルオキシベンゼン誘導体 |
| DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
| WO1999045905A2 (en) * | 1998-03-13 | 1999-09-16 | Pozen Inc. | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
| ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
| CN1665538A (zh) * | 2002-07-09 | 2005-09-07 | B·M·R·A·有限公司 | 血栓烷a2受体拮抗剂和cox－2抑制剂的药物组合 |
| WO2005016334A1 (en) * | 2003-08-07 | 2005-02-24 | B.M.R.A. Corporation B.V. | Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxigenase-1 |
| KR101275814B1 (ko) * | 2006-06-23 | 2013-06-18 | 삼성에스디아이 주식회사 | 분산제 화합물 및 그의 제조방법 |
| AU2008350907A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| CN101811974B (zh) * | 2010-04-15 | 2012-12-12 | 合肥医工医药有限公司 | 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途 |
| CN101851209B (zh) * | 2010-06-21 | 2012-09-19 | 合肥医工医药有限公司 | 咪唑乙基香草酸醚、其制备方法及其医药用途 |
| AR091112A1 (es) * | 2012-05-22 | 2015-01-14 | Genentech Inc | Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7 |
| US9388179B2 (en) | 2012-10-26 | 2016-07-12 | Merck Sharp & Dohme Corp. | N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels |
| WO2023240378A1 (zh) * | 2022-06-13 | 2023-12-21 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
| CN114736161B (zh) * | 2022-06-13 | 2022-09-13 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3534061A (en) * | 1967-12-04 | 1970-10-13 | Parke Davis & Co | N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles |
| US4085209A (en) * | 1975-02-05 | 1978-04-18 | Rohm And Haas Company | Preparation and safening effect of 1-substituted imidazole metal salt complexes |
| US4078071A (en) * | 1976-03-08 | 1978-03-07 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkyl imidazoles |
| JPS5951943B2 (ja) * | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
-
1979
- 1979-11-07 DK DK471479A patent/DK471479A/da not_active Application Discontinuation
- 1979-11-19 US US06/095,755 patent/US4602016A/en not_active Expired - Lifetime
- 1979-12-10 AR AR279215A patent/AR227637A1/es active
- 1979-12-10 GB GB7942535A patent/GB2038821B/en not_active Expired
- 1979-12-11 SE SE7910204A patent/SE444937B/sv unknown
- 1979-12-11 IL IL58917A patent/IL58917A/xx unknown
- 1979-12-11 ZA ZA00796708A patent/ZA796708B/xx unknown
- 1979-12-11 YU YU03018/79A patent/YU301879A/xx unknown
- 1979-12-11 NZ NZ192360A patent/NZ192360A/xx unknown
- 1979-12-11 IT IT41669/79A patent/IT1194900B/it active
- 1979-12-11 FI FI793868A patent/FI70888C/fi not_active IP Right Cessation
- 1979-12-11 ES ES486782A patent/ES486782A0/es active Granted
- 1979-12-11 PT PT70571A patent/PT70571A/pt unknown
- 1979-12-11 NL NLAANVRAGE7908899,A patent/NL177749C/xx not_active IP Right Cessation
- 1979-12-11 GR GR60727A patent/GR73003B/el unknown
- 1979-12-11 HU HU79PI699A patent/HU183016B/hu unknown
- 1979-12-12 AU AU53725/79A patent/AU517892B2/en not_active Ceased
- 1979-12-12 EG EG743/79A patent/EG14227A/xx active
- 1979-12-12 DE DE19792950019 patent/DE2950019A1/de not_active Ceased
- 1979-12-12 CA CA341,691A patent/CA1108137A/en not_active Expired
- 1979-12-12 BE BE0/198542A patent/BE880584A/fr not_active IP Right Cessation
- 1979-12-12 IE IE2403/79A patent/IE49318B1/en unknown
- 1979-12-12 PL PL1979220351A patent/PL134005B1/pl unknown
- 1979-12-12 LU LU81985A patent/LU81985A1/fr unknown
- 1979-12-12 SU SU792854456A patent/SU878195A3/ru active
- 1979-12-12 NO NO794069A patent/NO153135C/no unknown
- 1979-12-12 FR FR7930438A patent/FR2444031A1/fr active Granted
- 1979-12-12 CS CS798708A patent/CS216517B2/cs unknown
- 1979-12-12 AT AT0783379A patent/AT373879B/de not_active IP Right Cessation
- 1979-12-12 JP JP54161382A patent/JPS585197B2/ja not_active Expired
- 1979-12-12 KR KR1019790004397A patent/KR830001243B1/ko active
- 1979-12-13 CH CH1106279A patent/CH644597A5/de not_active IP Right Cessation
- 1979-12-13 PH PH23412A patent/PH15056A/en unknown
- 1979-12-13 DD DD79217645A patent/DD147943A5/de unknown
-
1985
- 1985-03-21 US US06/714,422 patent/US4636500A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES486786A0 (es) | Un procedimiento para la preparacion de carboxialquil-dipep-tidos. | |
| ES486782A0 (es) | Un procedimiento para la preparacion de derivados de imida- zol. | |
| ES497304A0 (es) | Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano. | |
| ES484097A0 (es) | Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas | |
| ES490214A0 (es) | Un procedimiento para la preparacion de derivados de feneta-nolamina | |
| ES477509A0 (es) | Un procedimiento para la preparacion de derivados de fenil- piperacina. | |
| ES479988A0 (es) | Un procedimiento para la preparacion de nuevos derivados - hete rociclicos. | |
| ES485619A0 (es) | Un procedimiento para la preparacion de derivados de diben- zopirano | |
| ES487843A0 (es) | Un procedimiento para la preparacion de derivados de imida- zol. | |
| ES488886A0 (es) | Un procedimiento para la preparacion de derivados acidos penemcarboxilicos. | |
| ES494131A0 (es) | Un procedimiento para la preparacion de diariltiofenos. | |
| ES491944A0 (es) | Un procedimiento para la preparacion de tienamicinas. | |
| ES495586A0 (es) | Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona. | |
| ES495163A0 (es) | Un procedimiento para la preparacion de derivados de carboestirilo. | |
| ES491835A0 (es) | Un procedimiento para la preparacion de mono-y-di-esteres desacarosa. | |
| ES490722A0 (es) | Un procedimiento para la preparacion de nuevos derivados de piridazina. | |
| ES485072A0 (es) | Un procedimiento para la preparacion de compuestos de 4-tia-zolidinona. | |
| ES507997A0 (es) | Un procedimiento para la preparacion de nuevos derivados de la quinoleina. | |
| ES484382A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-pirrolidin-metanol. | |
| ES486625A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzamida. | |
| ES482027A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fenetilamina. | |
| ES495589A0 (es) | Un procedimiento para la preparacion de derivados de imida- lol. | |
| ES481102A0 (es) | Un procedimiento para la preparacion de derivados de la in- danona. | |
| ES494130A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzoxocina. | |
| ES490277A0 (es) | Un procedimiento para la preparacion de aminoeteres. |